Chemotherapy of Aujeszky's disease (pseudorabies) in the mouse by means of nucleoside analogues: bromovinyldeoxyuridine, acyclovir, and dihydroxypropoxymethylguanine.

Abstract

Pseudorabies virus (PRV) infection was established in mice by means of inoculating the ear flap. The infection was universally fatal once clinical signs appeared. Bromovinyldeoxyuridine (BVDU) was a potent inhibitor of PRV in vitro, but this drug failed to protect mice and produced only marginal reductions in virus titre and slight prolongation of survival. Acyclovir (ACV) and dihydroxypropoxymethylguanine (DHPG) were both less active than BVDU when tested against the virus in BHK cells, yet DHPG therapy was extremely effective in mice; it reduced virus titres markedly and resulted in the long-term survival of mice given a potentially lethal infection. When ACV and DHPG were tested in vitro using murine rather than hamster cells, these compounds, especially DHPG, were shown to be much more active against PRV.

• Authors: H J Field
• Journal: Antiviral research (Antiviral Res) Vol. 5 Issue 3 Pg. 157-68 (Jun 1985) ISSN: 0166-3542 [Print] Netherlands
• PMID: 2992370 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antiviral Agents
• brivudine
• Bromodeoxyuridine
• Ganciclovir
• Acyclovir

Topics

• Acyclovir (analogs & derivatives, pharmacology, therapeutic use)
• Animals
• Antiviral Agents (pharmacology, therapeutic use)
• Bromodeoxyuridine (analogs & derivatives, pharmacology, therapeutic use)
• Cell Line
• Cells, Cultured
• Cricetinae
• Female
• Ganciclovir
• Herpesvirus 1, Suid (drug effects)
• Mice
• Mice, Inbred BALB C
• Pruritus (drug therapy)
• Pseudorabies (drug therapy)
• Time Factors
• Viral Plaque Assay